Forteris Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.3M Sell
1,992
-70
-3% -$82.6K 1.91% 19
2026
Q2
$2.47M Sell
2,062
-35
-2% -$35.8K 2.02% 18
2026
Q1
$1.93M Sell
2,097
-373
-15% -$378K 1.85% 20
2025
Q4
$2.65M Buy
+2,470
New +$2.36M 2.61% 15

Other funds holding LLY

Forteris Wealth Management's LLY Position: Q3 2026 in Review

Forteris Wealth Management reduced its Eli Lilly (LLY) stake by 3.4% in Q3 2026, selling an estimated $82.6K and leaving 1,992 shares worth $2.3M. The position accounts for 1.91% of the portfolio, ranked #19.

Forteris Wealth Management first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.65M in Q4 2025. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Forteris Wealth Management held 1,992 shares of Eli Lilly worth $2.3M as of Q3 2026.
  • Forteris Wealth Management sold 70 Eli Lilly shares in Q3 2026, an estimated $82.6K.
  • Eli Lilly made up 1.91% of Forteris Wealth Management's portfolio in Q3 2026, its #19 holding.
  • Forteris Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Forteris Wealth Management's Eli Lilly position peaked at $2.65M in Q4 2025.
  • 2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Forteris Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.